We Venture Capital logo

We Venture Capital

Description

Early stage diagnostics investor

Investor Profile

We Venture Capital has backed more than 6 startups, with 4 new investments in the last 12 months alone. The firm has led 3 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in United Kingdom, Sweden, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Seed (33%)
  • Series C (17%)

Country Focus

  • United Kingdom (50%)
  • Sweden (17%)
  • Canada (17%)
  • Spain (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Health Diagnostics
  • Precision Medicine
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does We Venture Capital frequently co-invest with?

Nina Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
Tenmile
Oceania, Western Australia, Australia, Perth
Co-Investments: 1
E
Europe, Veneto, Italy, San Giovanni Lupatoto
Co-Investments: 1
Co-Investments: 1
Sciety
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
15th Rock
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1

What are some of recent deals done by We Venture Capital?

Respiree

Singapore, Central Region, Singapore

Respiree is a healthcare service.

Health CareHome Health Care
Series AJul 23, 2025
Amount Raised: $11,600,000
Portal Biotech

London, England, United Kingdom

Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.

Biotechnology
Series AJun 30, 2025
Amount Raised: $37,073,704
DeepUll

Barcelona, Catalonia, Spain

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

BiotechnologyLife Science
Series CApr 29, 2025
Amount Raised: $57,074,303
OxCan

Oxford, Oxfordshire, United Kingdom

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

BiotechnologyHealth CareHealth Diagnostics
Series AJan 9, 2025
Amount Raised: $11,000,000
Proton Intelligence

Vancouver, British Columbia, Canada

Proton Intelligence provides biomarker monitoring to manage chronic disease and save lives.

Health CareHealth DiagnosticsMedicalMedical Device
SeedDec 24, 2024
Amount Raised: $6,950,000
Capitainer

Stockholm, Stockholms Lan, Sweden

Capitainer enables patients to collect their own volume-defined dried blood spot at home.

Health Care
Series AFeb 15, 2024
Amount Raised: $1,435,165
Zetta Genomics

Cambridge, Cambridgeshire, United Kingdom

Zetta Genomics manages large-scale genomic data for precision medicine.

BiotechnologyLife ScienceMedicalPrecision Medicine
SeedFeb 8, 2024
Amount Raised: $2,271,758

Find More Investors Like We Venture Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

We Venture Capital | Pipeseed